Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hypertension 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Sarcoma 1Radiation Injuries 1Prostatic Neoplasms 1Non-alcoholic Fatty Liver Disease 1Lymphoma, Follicular 1Lymphoma 1Hematologic Neoplasms 1Dyspnea 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

Nutrition Assessment 4Bevacizumab 3Lisinopril 2Labetalol 2Hydrochlorothiazide 2Angiotensin-Converting Enzyme Inhibitors 2ziprasidone 1pazopanib 1ganirelix 1enzalutamide 1clevidipine 1bicalutamide 1benazepril 1aliskiren 1Zolpidem 1Warfarin 1Vitamin D 1Vecuronium Bromide 1Vancomycin 1Urine Specimen Collection 1Tumor Necrosis Factors 1Tranexamic Acid 1Tobramycin 1Thiazides 1Therapeutics 1Surveys and Questionnaires 1Sunitinib 1Sulindac 1Standard of Care 1Spironolactone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Hypertension × Lisinopril × Clear all
NCT01234922 2018-08-28

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

Wake Forest University Health Sciences

Phase 2 Terminated
6 enrolled 10 charts

Hypertension

NCT01258764 2015-05-20

1HAT

Scripps Translational Science Institute

Phase NA Completed
2 enrolled
Lymphoid

Hypertension, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡